Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS safety_alert · 2025-08-01

Clinical Trial Update: Domperidone and the Risk of Serious Adverse Events

View source ↗

Summary

A clinical trial update highlights the risk of serious adverse events with domperidone, in patients with chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Domperidone (domperidone)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Chronic Kidney Disease (CKD) | Status: COMPLETED